Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea
AUTOR(ES)
Henneberg, Railson, Otuki, Michel Fleith, Furman, Aline Emmer Ferreira, Hermann, Priscila, Nascimento, Aguinaldo José do, Leonart, Maria Suely Soares
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2013
RESUMO
OBJECTIVE: The aim of this study was to evaluate the protective effects of quercetin, rutin, hesperidin and myricetin against reactive oxygen species production with the oxidizing action of tert-butylhydroperoxide in erythrocytes from normal subjects and sickle cell anemia carriers treated with hydroxyurea. METHODS: Detection of intracellular reactive oxygen species was carried out using a liposoluble probe, 2',7'-dichlorfluorescein-diacetate (DCFH-DA). A 10% erythrocyte suspension was incubated with flavonoids (quercetin, rutin, hesperidin or myricetin; 30, 50, and 100 µmol/L), and then incubated withtert-butylhydroperoxide (75 µmol/L). Untreated samples were used as controls. RESULTS: Red blood cell exposure to tert-butylhydroperoxide resulted in significant increases in the generation of intracellular reactive oxygen species compared to basal levels. Reactive oxygen species production was significantly inhibited when red blood cells were pre-incubated with flavonoids, both in normal individuals and in patients with sickle cell anemia. Quercetin and rutin had the highest antioxidant activity, followed by myricetin and hesperidin. CONCLUSION: Flavonoids, in particular quercetin and rutin, showed better antioxidant effects against damage caused by excess reactive oxygen species characteristic of sickle cell anemia. Results obtained with patients under treatment with hydroxyurea suggest an additional protective effect when associated with the use of flavonoids.
Documentos Relacionados
- Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
- Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil
- Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
- Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
- Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease